130 related articles for article (PubMed ID: 2522986)
1. Biochemical and electrophysiological evidence for an agonist action of CM 57493 at pre- and postsynaptic 5-hydroxytryptamine1A receptors in brain.
Adrien J; Lanfumey L; Gozlan H; Fattaccini CM; Hamon M
J Pharmacol Exp Ther; 1989 Mar; 248(3):1222-30. PubMed ID: 2522986
[TBL] [Abstract][Full Text] [Related]
2. New methoxy-chroman derivatives, 4[N-(5-methoxy-chroman-3-yl)N- propylamino]butyl-8-azaspiro-(4,5)-decane-7,9-dione [(+/-)-S 20244] and its enantiomers, (+)-S 20499 and (-)-S 20500, with potent agonist properties at central 5-hydroxytryptamine1A receptors.
Kidd EJ; Haj-Dahmane S; Jolas T; Lanfumey L; Fattaccini CM; Guardiola-Lemaitre B; Gozlan H; Hamon M
J Pharmacol Exp Ther; 1993 Feb; 264(2):863-72. PubMed ID: 8094756
[TBL] [Abstract][Full Text] [Related]
3. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.
Schechter LE; Bolaños FJ; Gozlan H; Lanfumey L; Haj-Dahmane S; Laporte AM; Fattaccini CM; Hamon M
J Pharmacol Exp Ther; 1990 Dec; 255(3):1335-47. PubMed ID: 1702155
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
[TBL] [Abstract][Full Text] [Related]
5. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
Jolas T; Haj-Dahmane S; Kidd EJ; Langlois X; Lanfumey L; Fattaccini CM; Vantalon V; Laporte AM; Adrien J; Gozlan H
J Pharmacol Exp Ther; 1994 Mar; 268(3):1432-43. PubMed ID: 8138956
[TBL] [Abstract][Full Text] [Related]
6. Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes.
Yocca FD; Iben L; Meller E
Mol Pharmacol; 1992 Jun; 41(6):1066-72. PubMed ID: 1352034
[TBL] [Abstract][Full Text] [Related]
7. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L
J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650
[TBL] [Abstract][Full Text] [Related]
8. Are postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat?
Jolas T; Schreiber R; Laporte AM; Chastanet M; De Vry J; Glaser T; Adrien J; Hamon M
J Pharmacol Exp Ther; 1995 Feb; 272(2):920-9. PubMed ID: 7853210
[TBL] [Abstract][Full Text] [Related]
9. Single-unit responses of serotonergic dorsal raphe neurons to 5-HT1A agonist and antagonist drug administration in behaving cats.
Fornal CA; Litto WJ; Metzler CW; Marrosu F; Tada K; Jacobs BL
J Pharmacol Exp Ther; 1994 Sep; 270(3):1345-58. PubMed ID: 7932189
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
Dumuis A; Sebben M; Bockaert J
Mol Pharmacol; 1988 Feb; 33(2):178-86. PubMed ID: 2828913
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiological comparison of 5-Hydroxytryptamine1A receptor antagonists on dorsal raphe cell firing.
Martin LP; Jackson DM; Wallsten C; Waszczak BL
J Pharmacol Exp Ther; 1999 Feb; 288(2):820-6. PubMed ID: 9918594
[TBL] [Abstract][Full Text] [Related]
12. Antagonist properties of (-)-pindolol and WAY 100635 at somatodendritic and postsynaptic 5-HT1A receptors in the rat brain.
Corradetti R; Laaris N; Hanoun N; Laporte AM; Le Poul E; Hamon M; Lanfumey L
Br J Pharmacol; 1998 Feb; 123(3):449-62. PubMed ID: 9504386
[TBL] [Abstract][Full Text] [Related]
13. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat.
Chaouloff F; Jeanrenaud B
J Pharmacol Exp Ther; 1987 Dec; 243(3):1159-66. PubMed ID: 2826757
[TBL] [Abstract][Full Text] [Related]
14. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists.
Millan MJ; Canton H; Gobert A; Lejeune F; Rivet JM; Bervoets K; Brocco M; Widdowson P; Mennini T; Audinot V
J Pharmacol Exp Ther; 1994 Jan; 268(1):337-52. PubMed ID: 8301575
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the activity of central serotoninergic neurons by novel serotonin1A receptor agonists and antagonists: a comparison to adrenergic and dopaminergic neurons in rats.
Gobert A; Lejeune F; Rivet JM; Audinot V; Newman-Tancredi A; Millan MJ
J Pharmacol Exp Ther; 1995 Jun; 273(3):1032-46. PubMed ID: 7791073
[TBL] [Abstract][Full Text] [Related]
16. Lack of 5-hydroxytryptamine1A-mediated inhibition of adenylyl cyclase in dorsal raphe of male and female rats.
Clarke WP; Yocca FD; Maayani S
J Pharmacol Exp Ther; 1996 Jun; 277(3):1259-66. PubMed ID: 8667186
[TBL] [Abstract][Full Text] [Related]
17. Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potential anxiolytic properties.
Hamon M; Fattaccini CM; Adrien J; Gallissot MC; Martin P; Gozlan H
J Pharmacol Exp Ther; 1988 Aug; 246(2):745-52. PubMed ID: 2457083
[TBL] [Abstract][Full Text] [Related]
18. Studies on the neuronal circuits involved in the discriminative stimulus effects of 5-hydroxytryptamine1A receptor agonists in the rat.
Schreiber R; de Vry J
J Pharmacol Exp Ther; 1993 May; 265(2):572-9. PubMed ID: 8496807
[TBL] [Abstract][Full Text] [Related]
19. Differential properties of pre- and postsynaptic 5-hydroxytryptamine1A receptors in the dorsal raphe and hippocampus: I. Effect of spiperone.
Blier P; Lista A; De Montigny C
J Pharmacol Exp Ther; 1993 Apr; 265(1):7-15. PubMed ID: 8474032
[TBL] [Abstract][Full Text] [Related]
20. Intrinsic activity of enantiomers of 8-hydroxy-2-(di-n-propylamino)tetralin and its analogs at 5-hydroxytryptamine1A receptors that are negatively coupled to adenylate cyclase.
Cornfield LJ; Lambert G; Arvidsson LE; Mellin C; Vallgårda J; Hacksell U; Nelson DL
Mol Pharmacol; 1991 Jun; 39(6):780-7. PubMed ID: 1828859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]